NVCT vs PNC · $304.5M cap vs P/E 14, rev $6.88B
Nuvectis Pharma Inc (NVCT) versus PNC Financial Services Group Inc (PNC) — a side-by-side from cached financials, not a winner call.
Nuvectis Pharma Inc (NVCT) is a biotechnology company listed on NASDAQ.
PNC Financial Services Group Inc (PNC) is a banks - regional company listed on US.
NVCT does not have a complete income-statement cache yet.
Latest reported PNC revenue for 2026-06-30 was $6.88B. Net income was $2.04B. Revenue was up 11.5% from 2026-03-31 to 2026-06-30. PNC currently screens at market cap $77.76B and trailing P/E 13.9.
NVCT currently screens at market cap $304.5M. PNC currently screens at market cap $77.76B and trailing P/E 13.9.
Not investment advice. Open the NVCT and PNC stock pages for the full models.
Not investment advice.